Celiac Disease
Anti-TTG and Endomysium IgA: a commonly used celiac disease screening.
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
Anti-TTG is the recommended first-line blood test for coeliac disease screening. Including this marker in a preventive health panel can help identify an often-underdiagnosed condition early, before complications such as nutrient deficiencies or bone loss develop.
This test measures the level of IgA antibodies directed against tissue transglutaminase in your blood. It is the most sensitive and specific single blood test for coeliac disease screening. For accurate results, you must be consuming gluten regularly at the time of testing.
Undiagnosed coeliac disease can lead to nutrient malabsorption, iron deficiency, osteoporosis, and other complications. Early detection through anti-TTG screening enables timely dietary management. A negative result in someone already following a gluten-free diet may be falsely reassuring.
Consider testing if you experience persistent digestive symptoms such as bloating, diarrhoea, or abdominal pain after eating gluten-containing foods. Testing is also recommended if you have a family history of coeliac disease, iron-deficiency anaemia of unknown cause, or associated autoimmune conditions. You must be eating gluten for at least 6 weeks before testing.
If coeliac disease is confirmed, a strict lifelong gluten-free diet is the primary treatment. Even small amounts of gluten can trigger immune activity. Work with a dietitian to ensure nutritional adequacy. Do not start a gluten-free diet before testing is complete, as this can produce falsely negative results.
This marker is included in the following test panels.
Anti-TTG and Endomysium IgA: a commonly used celiac disease screening.